Under construction – not a live service
Sign in
Taking peoplePhase 3

Effect of Some Drugs on Liver Fibrosis

Key facts

Phase
Phase 3

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Sherief Abd-Elsalam
Trial code
NCT03770936
Record updated
10 December 2018
Original description
Effect of Some Drugs on Liver FibrosisRead full original descriptionShow less

Clinical Study Evaluating the Efficacy of Renin Angiotensin System Inhibitors on the Extent of Liver Fibrosis in Patients With Chronic Hepatitis C

Effect of Some Drugs on Liver Fibrosis

Inclusion: chronic hepatitis C.

Exclusion: Acute hepatitis; Thalassemia.

ClinicalTrials.gov NCT03770936